|
Volumn 60, Issue 13-14, 1997, Pages 969-976
|
In vivo pharmacology of butylthio[2.2.2](LY297802/NNC11-1053), and orally acting antinociceptive muscarinic agonist
|
Author keywords
antinociception; butylthio 2.2.2 ; M2 antagonist
|
Indexed keywords
3 (4 BUTYLTHIO 1,2,5 THIADIAZOL 3 YL)QUINUCLIDINE;
3 [4 BUTYLTHIO 1,2,5 THIADIAZOL 3 YL] 1 AZABICYCLO[2.2.2]OCTANE;
ANALGESIC AGENT;
ARECOLINE DERIVATIVE;
MORPHINE;
MUSCARINIC AGENT;
MUSCARINIC M1 RECEPTOR;
MUSCARINIC M2 RECEPTOR;
MUSCARINIC M2 RECEPTOR ANTAGONIST;
MUSCARINIC M3 RECEPTOR;
MUSCARINIC M4 RECEPTOR;
MUSCARINIC RECEPTOR;
MUSCARINIC RECEPTOR BLOCKING AGENT;
NEUROTRANSMITTER RECEPTOR;
OXOTREMORINE M;
PIRENZEPINE;
QUINUCLIDINYL BENZILATE;
RADIOLIGAND;
RECEPTOR SUBTYPE;
SCOPOLAMINE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINOCICEPTION;
BLADDER;
COMPETITIVE INHIBITION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG ANTAGONISM;
GUINEA PIG;
HEART ATRIUM;
HOT PLATE TEST;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RABBIT;
RAT;
RECEPTOR AFFINITY;
SALIVATION;
SUBCUTANEOUS DRUG ADMINISTRATION;
TAIL FLICK TEST;
TREMOR;
VAS DEFERENS;
WRITHING TEST;
ADMINISTRATION, ORAL;
ANALGESICS, NON-NARCOTIC;
ANIMALS;
GUINEA PIGS;
MICE;
MUSCARINIC AGONISTS;
RABBITS;
RATS;
THIADIAZOLES;
|
EID: 0030984542
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(97)00036-2 Document Type: Conference Paper |
Times cited : (20)
|
References (24)
|